Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-Coated Tablets for Cats
Milbemycin Oxime (A3 and A4), Praziquantel
Last verified
Veterinary medicinal product: coated tablet. Distribution category: POM-V (Veterinary Medicines Regulations 2013, Schedule 3). Active substance: Milbemycin Oxime (A3 and A4), Praziquantel.1
In short: questions and answers
- Does Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-Coated Tablets for Cats need a prescription?
- Prescription only. As stated in the registration decision.1
- Which animals is Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-Coated Tablets for Cats for?
- Cats.1
- What is the active substance in Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-Coated Tablets for Cats?
- Milbemycin Oxime (A3 and A4), Praziquantel. ATCvet code: QP54AB51.13
- What is the withdrawal period of Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-Coated Tablets for Cats according to the leaflet?
- No withdrawal period is set for this drug: it is not intended for food-producing animals.3
- Dispensing
- Prescription only1
POM-V: Prescription Only Medicine - Veterinarian. Supplied only on a prescription written by a veterinary surgeon who has assessed the animal.12
Supplied only on a veterinarian's prescription. As stated in the registration decision.
- Animal species
- Cats1
- Active substance
- Milbemycin Oxime (A3 and A4), Praziquantel
- ATCvet code
- QP54AB513
- Manufacturer
- Marketing authorisation holder: Elanco Europe Ltd
Withdrawal period
No withdrawal period is set for this drug: it is not intended for food-producing animals.3
Summary of product characteristics
Composition
One tablet contains:
Active substances:
Milbemycin oxime 16 mg
Praziquantel 40 mg
Excipients:
Iron oxide (E172) 0.288 mg
For a full list of excipients, see section 6.1.
6.1 List of excipients
Core:
Cellulose, microcristalline
Croscarmellose sodium
Povidone
Lactose monohydrate
Silica, colloidal anhydrous
Magnesium stearate
Coat:
Hypromellose
Macrogol
Talc
Iron oxide red
Artificial beef flavour
Pharmaceutical form
Film-coated tablet.
Oblong shaped, reddish to reddish brown, artificial beef flavoured tablet with a score on both sides. One side bears the imprint “KK”, the other side “NA”.
Pharmacological properties
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellants - endectocides
ATC vet Code: QP54AB51 (milbemycin oxime, combinations)
5.1 Pharmacodynamic properties
Milbemycin oxime belongs to the group of macrocyclic lactones, isolated from the fermentation of Streptomyces hygroscopicus var. aureolacrimosus. It is active against mites, against larval and adult stages of nematodes as well as against larvae of Dirofilaria immitis.
The activity of milbemycin is related to its action on invertebrate neurotransmission: Milbemycin oxime, like avermectins and other milbemycins, increases nematode and insect membrane permeability to chloride ions via glutamate-gated chloride ion channels (related to vertebrate GABAA and glycine receptors). This leads to hyperpolarisation of the neuromuscular membrane and flaccid paralysis and death of the parasite.
Praziquantel is an acylated pyrazino-isoquinoline derivative. Praziquantel is active against cestodes and trematodes. It modifies the permeability for calcium (influx of Ca2+) in the membranes of the parasite inducing an imbalance in the membrane structures, leading to membrane depolarisation and almost instantaneous contraction of the musculature (tetany), rapid vacuolization of the syncytial tegument and subsequent tegumental disintegration (blebbing), resulting in easier expulsion from the gastrointestinal tract or death of the parasite.
5.2 Pharmacokinetic particulars
In the cat, praziquantel reaches peak plasma concentrations within an hour after oral administration.
The half life of elimination is around 3 hours.
In the dog, there is rapid hepatic biotransformation, prinicipally to monohydroxylated derivatives.
The principal route of elimination in the dog is renal.
After oral administration in the cat, milbemycin oxime reaches peak plasma concentrations within 2 hours. The half life of elimination is around 13 hours (± 9 hours). In the rat, metabolism appears to be complete although slow, since unchanged milbemycin oxime has not been found in urine or feces. Main metabolites in the rat are monohydroxylated derivatives, attributable to hepatic biotransformation. In addition to relatively high liver concentrations, there is some concentration in fat, reflecting its lipophilicity.
Target species
Cats
Indications
In cats: treatment of mixed infections by immature and adult cestodes and nematodes of the following species:
- Cestodes:
Dipylidium caninum
Taenia spp.
Echinococcus multilocularis
- Nematodes:
Ancylostoma tubaeforme
Toxocara cati
Prevention of heartworm disease (Dirofilaria immitis) if concomitant treatment against cestodes is indicated.
Dosage
Minimum recommended dose rate: 2 mg of milbemycin oxime and 5 mg of praziquantel per kg are given orally as a single dose. The product should be administered with or after some food. Doing so ensures optimum protection against heartworm disease.
Depending on the bodyweight of the cat, the practical dosing is as follows:
| Weight | Tablets |
|---|---|
| 2 - 4 kg | ½ tablet |
| > 4 - 8 kg | 1 tablet |
| > 8 - 12 kg | 1½ tablets |
Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-coated Tablets for Cats can be inserted into a programme for prevention of heartworm disease if at the same time treatment against tapeworms is indicated. Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-coated Tablets for Cats has a duration of heartworm prevention of one month. For regular prevention of heartworm disease the use of a monosubstance is preferred.
Contraindications
Do not use in cats weighing less than 2 kg.
Adverse reactions
In very rare occasions, especially in young cats, hypersensitivity reactions, systemic signs (such as lethargy), neurological signs (such as ataxia and muscle tremors) and/or gastrointestinal signs (such as emesis and diarrhoea) have been observed after administration of the veterinary medicinal product.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Warnings
Special precautions for use in animals
As per good veterinary practice, animals should be weighed to ensure accurate dosing. Ensure cats and kittens weighing between 0.5 kg and ≤2 kg receive the appropriate tablet strength (4 mg MBO/10 mg praziquantel) and the appropriate dose (1/2 or 1 tablet) for the corresponding weight band (1/2 tablet for cats weighing 0.5 to 1 kg ; 1 tablet for cats weighing >1 to 2 kg – 1 tablet).
Echinococcosis represents a hazard for humans. In case of Echinococcosis, specific guidelines on the treatment and follow up and on the safeguard of persons have to be followed. Experts or institutes of parasitology should be consulted.
No studies have been performed with severely debilitated cats or individuals with seriously compromised kidney or liver function. The product is not recommended for such animals or only according to a benefit/risk assessment by the responsible veterinarian.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Wash hands after use.
In the event of accidental ingestion of the tablets, particularly by a child, seek medical advice immediately and show the package leaflet or the label to the physician.
Use during pregnancy, lactation or lay
Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-coated Tablets for Cats can be used in breeding cats including pregnant and lactating queens.
Interactions
The concurrent use of Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-coated Tablets for Cats with selamectin is well tolerated. No interactions were observed when the recommended dose of the macrocyclic lactone selamectin was administered during treatment with Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-coated Tablets for Cats at the recommended dose.
Although not recommended, the concomitant use of Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-coated Tablets for Cats with a spot on containing moxidectin and imidacloprid at recommended dose rates following a single application was well tolerated in one laboratory study in 10 kittens.
The safety and efficacy of the concurrent use have not been investigated in field studies. In the absence of further studies, caution should be taken in the case of concurrent use of the product with any other macrocyclic lactone. Also, no such studies have been performed with reproducing animals.
Overdose
In case of overdose, in addition to signs observed at the recommended dose (see section 4.6), drooling was observed. This sign will usually disappear spontaneously within a day.
Special warnings
In order to develop an effective worm control programme local epidemiological information and the risk of exposure of the cat should be taken into account. It is recommended to treat all the animals living in the same household concomitantly. When infection with the cestode D. caninum has been confirmed, concomitant treatment against intermediate hosts, such as fleas and lice, should be discussed with a veterinarian to prevent re-infection.
Withdrawal period
Not applicable.
Incompatibilities
Not applicable.
Immediate packaging
PVC/PE/PVdC/aluminium blister
Available pack sizes:
Box with 2 tablets in blister
Box with 4 tablets in blister
Box with 10 tablets in blister
Box with 20 tablets in blister
Box with 50 tablets in blister
Box with 100 tablets in blister
Not all pack sizes may be marketed
Storage
Do not store above 25 °C
Keep the blister in the outer carton in order to protect from light
Shelf life
Shelf-life of the veterinary medicinal product as packaged for sale: 3 years
Shelf-life after first opening of the immediate packaging: 6 months
Disposal of unused product
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-coated Tablets for Cats should not enter water courses as this may be dangerous for fish and other aquatic organisms.
Additional information
Vm 00879/5010
9 DATE OF FIRST AUTHORISATION
29 December 2022
10 DATE OF REVISION OF THE TEXT
December 2022
Approved 29 December 2022
Registration holder
Elanco Europe Ltd
Form 2, Bartley Way
Bartley Wood Business Park
Hook
RG27 9XA
United Kingdom
Regulations
- Veterinary Medicines Regulations 2013 (SI 2013/2033), Schedule 32
Sources
- VMD Product Information Database: Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-Coated Tablets for Cats, 00879/5010
- The Veterinary Medicines Regulations 2013, Schedule 3 (categories of veterinary medicinal products)
- Summary of Product Characteristics: Elanco Milbemycin - Praziquantel 16 mg/40 mg Film-Coated Tablets for Cats
Other products with the same active substance
- Aderexa 12.5 mg/125 mg Chewable Tablets for Dogs Weighing at Least 5 kg
- Aderexa 2.5 mg/25 mg Chewable Tablets for Small Dogs and Puppies Weighing at Least 0.5 kg
- Alpramil 12 mg/30 mg Film-coated Tablets for Cats Weighing at Least 3 kg
- Alpramil 12.5 mg/125 mg Tablets for Dogs Weighing at Least 5 kg
- Alpramil 16 mg/40 mg Film-coated Tablets for Cats Weighing at Least 4 kg
- Alpramil 20 mg/200 mg Tablets for Dogs Weighing at Least 8 kg
- Alpramil 4 mg/10 mg Film-coated Tablets for Cats Weighing at Least 0.5 kg
- Alpramil 5 mg/50 mg Tablets for Dogs Weighing at Least 0.5 kg
- Amcofen 2.5 mg/25 mg Chewable Tablets for Small Dogs and Puppies Weighing at Least 0.5 kg
- Credelio Plus 112.5 mg/4.22 mg Chewable Tablets for Dogs (>2.8 kg - 5.5 kg)
- Credelio Plus 225 mg/8.44 mg Chewable Tablets for Dogs (>5.5 kg - 11 kg)
- Credelio Plus 450 mg/16.88 mg Chewable Tablets for Dogs (>11 kg- 22 kg)
All products with this active substance (114)
The same active substance in other countries
Spain
- ALPRAMIL 12,5 mg/ 125 mg COMPRIMIDOS PARA PERROS QUE PESEN AL MENOS 5 Kg
- ALPRAMIL 16 mg/40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA PARA GATOS QUE PESEN AL MENOS 4 Kg
- ALPRAMIL 20 mg/ 200 mg COMPRIMIDOS PARA PERROS QUE PESEN AL MENOS 8 Kg
- MEKTIX 12,5 mg / 125 mg COMPRIMIDOS MASTICABLES PARA PERROS QUE PESEN AL MENOS 5 Kg
- MEKTIX 2,5 mg / 25 mg COMPRIMIDOS MASTICABLES PARA PERROS PEQUEÑOS Y CACHORROS QUE PESEN AL MENOS 0,5 kg
All products with this active substance (27)
Poland
- Alpramil 12 mg/30 mg tabletki powlekane dla kotów o masie ciała co najmniej 3 kg
- Alpramil 12,5 mg/125 mg tabletki dla psów o masie ciała co najmniej 5 kg
- Alpramil 16 mg/40 mg tabletki powlekane dla kotów o masie ciała co najmniej 4 kg
- Alpramil 20 mg/200 mg tabletki dla psów o masie ciała co najmniej 8 kg
- Alpramil 4 mg/10 mg tabletki powlekane dla kotów o masie ciała co najmniej 0,5 kg
All products with this active substance (42)
Ukraine
- Кределіо ПЛЮС (таблетки жувальні)
- Мілпразон® Плюс Milprazon® Plus жувальні таблетки, покриті плівкою, для котів
- Мілпразон® Плюс Milprazon® Plus жувальні таблетки, покриті плівкою, для маленьких котів та кошенят
- Мілпразон® Плюс Milprazon® Plus жувальні таблетки, покриті плівкою, для маленьких собак та цуценят
- Мілпразон® Плюс Milprazon® Plus жувальні таблетки, покриті плівкою, для собак